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Using a panel of monoclonal antibodies, it has previously been demonstrated that the cytosol of nucleated red cells (trout and turkey) contains 
a protein similar to arrestin, a soluble protein found so far only in the photosensitive cells and which, by binding to photoexcited rhodopsin, inhibits 
the phototransduction process. The role of this arrestin-like protein in non-photosensitive cells is questionable. In this report we present evidence 
that partially purified red blood cell arrestin (RBC arrestin) behaves functionally like bovine retinal arrestin: it binds to phosphorylated bovine 
rhodopsin only when this receptor has been photoactivated. Thus RBC arrestin and bovine retinal arrestin are closely related both structurally 
and functionally. By analogy with the function of retinal arrestin, it is proposed that RBC arrestin is involved in desensitization of membrane 
transport proteins and/or adrenergic receptors. 
Arrestin; Erythrocyte; p Adrenergic transduction; Na/H antiport; Phototransduction; Trout; Turkey 
1. INTRODUCTION 
The response of a retinal rod cell to a flash of light is 
mediated by a receptor/GTP-binding protein (rhodop- 
sin/transducin) signal transduction system. Absorption 
of light by rhodopsin leads to conformational changes 
in the rhodopsin molecule [l]. This photoexcited 
rhodopsin activates the cGMP cascade of visual trans- 
duction and is then partially deactivated through its 
phosphorylation by a specific protein kinase (rhodopsin 
kinase)[2]. Binding of arrestin, a 48 kDa cytosolic pro- 
tein, to the photoexcited and phosphorylated rhodopsin 
potentiates this inhibitory effect, leading to almost 
complete arrest of the transduction cascade. This pro- 
cess involves a competition between arrestin and trans- 
ducin for interaction with rhodopsin. Arrestin does not 
bind to rhodopsin in the absence of phosphorylation of 
the photoexcited rhodopsin [3,4]. Partly because of its 
regulatory role in phototransduction and partly because 
its immunocytochemical detection is restricted to ver- 
tebrate and invertebrate photoreceptors, arrestin was 
considered to be a specific marker of photosensitive 
cells and photoreceptor-derived cells of the pineal gland 
[5,6]. Recently however, we have demonstrated[7] that 
turkey and trout nucleated red cells, and extracts of 
several bovine organs, contain a cytosolic protein which 
is similar to retinal arrestin as regards its electrophoretic 
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mobility in SDS-PAGE and immunoreactivity with a 
panel of monoclonal and polyclonal anti-arrestin an- 
tibodies. This report demonstrates that the arrestin-like 
protein extracted from trout red blood cells (RBC) 
functionally behaves like retinal arrestin, i.e. the RBC 
arrestin binds to phosphorylated bovine rhodopsin only 
when it has been photoactivated. 
2. MATERIALS AND METHODS 
2.1. Preparation of RBC arrestin 
The first step in preparing arrestin-like protein from erythrocytes is 
to remove hemoglobin by ammonium salt precipitation. The pro- 
tocole used to prepare and to lyse erythrocytes has previously been 
described [7]. 
2.2. Processing of fractions 
Fractionation of soluble cytosolic proteins on a FPLC-gel filtration 
cohmm. The FPLC column was loaded with the ammonium sulfate 
precipitate (1.5 mg protein/ml); flow rate 0.4 ml/min with elution 
buffer (20 mM Tris-HCI, 50 mM NaCl, pH 7.5). Total protein con- 
tent and reactivity in ELISA were measured on all the fractions eluted 
as described in [7]. 
Zmmunoaffinity chromatography. The fractionation of a cytosolic 
extract from red cells, previously enriched by FPLC gel filtration, was 
obtained on a column of the monoclonal antibody SgEa to bovine ar- 
restin coupled to CNBr-activated sepharose. Methods as in [7]. 
2.3. Zmmunoassays 
Antibodies: bovine arrestin is a single chain containing 404 amino- 
acids. Four monoclonal antibodies to arrestin were used in this study. 
Mapping of epitopes recognized by these antibodies on the amino- 
acid sequence of bovine retinal arrestin has allowed location of the 
epitopes for SzDz and SsHs in the N-terminal region, the epitope for 
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&Es in the C-terminus and the epitope for M4Hia in the sequence of 
amino-acid 283-302. ELISA and Western blot techniques using 
monoclonal antibodies have been previously described [7]. An im- 
munometric assay has been developed allowing the protein sandwich- 
ed between a C- and a N-terminal monoclonal anti-arrestin antibody 
to be titrated very specifically : 96-well microplates were coated with 
the N-terminal anti-arrestin antibody S6Hs; plates were incubated 
with cytosolic extracts, washed, then reincubated with the C-terminal 
monoclonal antibody S9E2 coupled with acetylcholinesterase [14] and 
finally washed. Ellman reagent was used to measure the acetyl- 
cholinesterase activity fixed on arrestin [15]. A standard curve was 
established by using different concentrations of bovine retinal ar- 
restin. 
2.4. Experimental system used to assay the binding of RBC 
arrestin to bovine rhodopsin contained in disc membrane 
Rod outer segment (ROS) disc membranes were purified from fresh 
bovine retina [8] and stored under nitrogen at - 80°C. Rhodopsin is 
by far the predominant protein in the disc membrane. Two types of 
material were obtained from the ROS. One batch of ROS was exten- 
sively washed in dark condition to remove retinal arrestin (washing 
solution : 5 mM Tris, 1 mM Mg, pH 7.5). The disc membranes con- 
taining non-activated, arrestin-free rhodopsin were then conserved 
(a). A second batch of ROS was illuminated, inducing the fixation of 
soluble retinal arrestin on photoactivated and phosphorylated 
rhodopsin. The rhodopsin-containing pellet was discarded. The 
supernatant, free of retinal arrestin (as shown in Fig. 3a lane 2) but 
containing other soluble compounds including rhodopsin kinase was 
kept (b). The binding of RBC arrestin to bovine rhodopsin was 
essayed first by mixing in the dark: non-activated arrestin-free 
rhodopsin (a), arrestin-free soluble compounds (b) and the RBC 
cytosolic extract containing RBC arrestin (all freshly prepared), 3 mM 
ATP and 0.1 mM GTPyS (to keep transducin in the active form, not 
competing with arrestin). In a second step the above mixture was 
either maintained in the dark or exposed to light. 
2.5. Binding of RBC arrestin to solubilized rhodopsin adsorbed to 
ELISA Plates 
ROS disc membranes were extensively washed in the dark (to wash 
out internal arrestin). They were illuminated in the presence of an ar- 
restin-free supernatant but containing rhodopsin kinase and sup- 
plemented with ATP and GTPyS. Solubilization of the photoac- 
tivated and phosphorylated rhodopsin, theoretically free of bovine 
retinal arrestin, was performed in a solution containing 5 mM Tris- 
HCl, 1 mM MgC12, 0.5% Triton X-100 ‘reduced’ Sigma. Solubilized 
rhodopsin was adsorbed overnight to ELISA plates (4°C) in ELISA 
coupling buffer pH 9.6. The fixed rhodopsin was then incubated with 
RBC extract freshly obtained by FPLC-gel filtration, or with a solu- 
tion containing bovine retinal arrestin. Reactivity in ELISA with 
monoclonal antibodies was then tested. 
3. RESULTS AND DISCUSSION 
Figure la shows the elution profile of trout erythro- 
cyte cytosolic extract from FPLC gel filtration. The ef- 
fluents collected in fractions 1-15 contained a large 
amount of proteins which did not significantly react in 
ELISA with either C- or N-terminal directed monoclo- 
nal antibodies. The main immunological response oc- 
curs in the region where proteins smaller than 60 kDa 
are eluted (fractions 18-21). Elution and immunologi- 
cal reactivity profiles of turkey erythrocytes were 
similar to those of trout erythrocyte (not shown). The 
proteins contained in these fractions enriched by FPLC 
were characterized after migration in SDS-PAGE. 
Figure lb shows the total proteins, stained by Coomas- 
sie blue, contained in turkey (lane 1) and trout (lane 2) 
erythrocytes : in these fractions the high molecular mass 
proteins have been discarded but there are still many 
proteins in the 20-60 kDa range. However, on the same 
fractions after transfer from the SDS gel to PVDF- 
immunoblot membrane, only one protein was immuno- 
reactive with antibodies to arrestin (Fig. lc). The ap- 
parent molecular mass of the immunoreactive protein 
was slightly lower than 48 kDa in trout erythrocytes, 
and higher in turkey erythrocytes. An additional char- 
acterization of the arrestin-like protein of these frac- 
tions was obtained by developing an immunometric test 
allowing the protein sandwiched between a C- and an 
N-terminal monoclonal anti-arrestin antibody to be 
titrated very specifically as illustrated in Fig. 3b. Fur- 
ther purification of the arrestin-like protein was carried 
out by immunoaffinity chromatography using the 
monoclonal antibody S9E2 coupled to a cyanogen- 
bromide-activated gel. The elution profile is. shown in 
Fig. 2a : the fractions corresponding to peaks 1 and 2, 
collected during the washing of the column, contained 
a large percentage of the total proteins which did not 
react with anti-arrestin antibodies (Fig. 2b). Converse- 
ly, the small amount retained by the column and eluted 
at low pH showed a very high arrestin-like immunore- 
activity. Thus the arrestin-like protein was specifically 
retained by the antibody fixed on the gel, and the 
enrichment with the affinity column is very efficient. 
Unfortunately an irreversible aggregation of the ar- 
restin protein was observed under elution at pH 2.5 as 
shown by Western blots in which only bands of high 
molecular mass were seen (not shown). Consequently, 
to test whether the arrestin-like protein found in RBC 
can bind to rhodopsin and whether this binding is light- 
induced, we used extracts only enriched by FPLC but 
containing the protein in the native form. 
The experiments were performed with extracts from 
trout RBC and using the reconstituted experimental 
system described in section 2. Rod outer segment disc 
membranes from bovine retina, washed in the dark and 
thus containing rhodopsin in the non-activated form, 
were suspended in a medium containing both trout 
RBC arrestin and soluble compounds allowing rhodop- 
sin phosphorylation (rhodopsin kinase and ATP). It is 
expected that absorption of light by rhodopsin in disc 
membranes will lead to conformational changes in the 
rhodopsin molecule making it available as a substrate 
for the kinase and then allowing the light-induced bin- 
ding of arrestin. The data are similar whether obtained 
from immunoblot (Fig. 3a), by ELISA (Fig. 3b) or by 
an immunometric assay which allows very specific titra- 
tion of the arrestin-like protein (Fig. 3~). They show 
that almost all of the RBC arrestin contained in the 
medium in contact with dark membrane disappears 
from the medium during the illumination period in- 
dicating that RBC arrestin, like retinal arrestin, binds to 
rhodopsin when this protein becomes photoactivated 
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Fig. l(a). Fractionation of soluble cytosolic proteins from trout erythrocytes on a FPLC-gel filtration column. The reactivity in ELISA of the dif- 
ferent fractions was measured with two monoclonal anti-arrestin antibodies (SzD2 = N-terminal, S9EZ I C-terminal). (b) Gel electrophoresis of 
total proteins (Coomassie blue stained) contained in pooled arrestin-enriched fractions of RBC turkey (1) and trout (2) cytosolic extracts; lane 3: 
bovine purified arrestin; lane 4 : molecular mass markers. (c) Immunoblots of the same fractions (reactivity with the antibody SeHs). A similar 
result was obtained by using the other monoclonal antibodies. 
and phosphorylated. Conversely the control disc mem- 
branes, not illuminated, do not fix RBC arrestin. 
This result was confirmed in another type of experi- 
ment where solubilized rhodopsin, previously photoac- 
tivated and phosphorylated, was adsorbed on poly- 
ethylene microplates. It can be observed, as shown in 
Fig. 4, that trout RBC arrestin, like bovine retinal ar- 
restin, binds to the rhodopsin-coated surface. 
Our data suggest that RBC arrestin could have a 
functional role closely related to that of retinal arrestin. 
However, since red blood cells are not photosensitive 
cells, a target other than rhodopsin must be identified. 
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Fig. 2. Immunoaffinity chromatography. Fractionation of a cytosolic extract from RBC turkey, previously enriched by FPLC-gel filtration, on 
a column of the monoclonal antibody &Ez to bovine arrestin coupled to CNBr-activated Sepharose. (a) Elution profile of proteins; (b) Im- 
munoreactivity with C- and N-terminal monoclonal antibodies to arrestin. The fractions eluted with acidic buffer positively react in ELISA with 
both antibodies. 
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Fig. 3. Experiments howing the light-dependent binding of trout RBC arrestin to ROS disc membranes. (a) Immuno-detection of the RBC arrestin 
in the supernatants obtained from a binding assay experiment in which disc membranes were illuminated (lane 3) or kept in the dark (lane 4). After 
electrophoretic migration in SDS-PAGE, proteins were electro-transferred to PVDF membranes and incubated with an anti-arrestin antibody (in 
this experiment : the C-terminal monoclonal SUEZ). The labeling of the antibody was obtained by fixation of radiolabeled protein A. This 
autoradiography shows the presence of RBC arrestin in the supernatant under dark control conditions (lane 4) and its disappearance after illumina- 
tion (lane 3). Lane 2 shows that no residual endogenous retinal arrestin could be detected in the supernatant before RBC arrestin was added for 
the experiment. Lane [l]: bovine retinal arrestin as control. (b) Reactivity in ELISA of the supernatants, with or without illumination, measured 
either with two different monoclonal antibodies (S& = C-terminal; S2D2 = N-terminal) as described previously [7] or by the immunometric assay. 
0.0 
Fig. 4. Experiments showing the light-dependent binding of trout 
RBC arrestin to solubilized rhodopsin, previously photoexcited and 
phosphorylated, and then adsorbed to ELISA plates. It can be observ- 
ed that the fixed rhodopsin incubated in the absence of arrestin 
(rhodopsin-control), reacts significantly in ELISA with the 
monoclonal antibodies S2D2 and S9E2: it is due to the tight binding of 
some endogenous arrestin to residual photoactivated rhodopsin due 
to incomplete dark adaptation at the time of slaughtering. Addition 
of either trout RBC arrestin or bovine retinal arrestin in the medium 
causes a large increase in the immunological signal, indicating the bin- 
ding of both types of arrestin to the previously photoactivated and 
phosphorylated rhodopsin. 
control retinal trout RBC 
arrestin arrestin 
During the course of this work it has been reported that 
a complementary DNA from an arrestin-like protein 
was cloned in bovine brain [9], supporting our previous 
observation that arrestin-like proteins have a wide- 
spread distribution [7]. This arrestin-like protein has 
been expressed and shown to inhibit P-receptor func- 
tion. Thus, the authors propose that it is involved in & 
receptor desensitization in a similar way as retinal ar- 
restin is involved in rhodopsin desensitization. Taking 
into account the analogies between visual and ,8 
adrenergic systems [lo], this suggestion appears very 
likely. In trout RBC, however, no desensitization of ,8- 
receptors is observed over several hours whereas a ,8 
adrenergic-dependent membrane transport system 
(Nal/H) antiporter) is very rapidly (2 min) and exten- 
sively desensitized [111. Similarly in turkey red blood 
cells, the/3 adrenergic-dependent Na/K/Cl co-transport 
becomes desensitized [ 121. Thus the possibility arises, as 
previously proposed [ 131, that arrestin-like proteins 
found in non-photosensitive cells are regulatory 
elements involved in the desensitization of various types 
of membrane proteins such as transport proteins 
and/or receptors . 
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